4//SEC Filing
TANG KEVIN C 4
Accession 0001209191-20-052437
CIK 0001717452other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:01 PM ET
Size
14.2 KB
Accession
0001209191-20-052437
Insider Transaction Report
Form 4
TANG CAPITAL MANAGEMENT LLC
10% Owner
Transactions
- Purchase
Common Stock
2020-09-29$13.85/sh+10,882$150,698→ 15,238,782 total(indirect: By LP) - Purchase
Common Stock
2020-09-28$13.06/sh+100,000$1,305,710→ 15,227,900 total(indirect: By LP)
TANG KEVIN C
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2020-09-28$13.06/sh+100,000$1,305,710→ 15,227,900 total(indirect: By LP) - Purchase
Common Stock
2020-09-29$13.85/sh+10,882$150,698→ 15,238,782 total(indirect: By LP)
Hearne Michael S
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-09-28$13.06/sh+100,000$1,305,710→ 15,227,900 total(indirect: By LP) - Purchase
Common Stock
2020-09-29$13.85/sh+10,882$150,698→ 15,238,782 total(indirect: By LP)
TANG CAPITAL PARTNERS LP
10% Owner
Transactions
- Purchase
Common Stock
2020-09-28$13.06/sh+100,000$1,305,710→ 15,227,900 total(indirect: By LP) - Purchase
Common Stock
2020-09-29$13.85/sh+10,882$150,698→ 15,238,782 total(indirect: By LP)
Lemkey John G
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-09-28$13.06/sh+100,000$1,305,710→ 15,227,900 total(indirect: By LP) - Purchase
Common Stock
2020-09-29$13.85/sh+10,882$150,698→ 15,238,782 total(indirect: By LP)
Footnotes (3)
- [F1]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $12.71 to $13.19. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in footnotes 1 and 3 herein.
- [F2]The securities are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. The shares reported as beneficially owned by TCP include a total of 154,285 shares of common stock that are held of record by Odonate Holdings, LLC ("Holdings"). Holdings has granted a proxy to TCP giving TCP the sole authority to vote such shares. John Lemkey is the Chief Operating Officer of Odonate Therapeutics, Inc., as well as Chief Operating Officer of TCM. Michael Hearne is the Chief Financial Officer of Odonate Therapeutics, Inc., as well as Chief Financial Officer of TCM. Mr. Tang, Mr. Lemkey and Mr. Hearne each have a pecuniary interest in a portion of the shares beneficially held by TCP.
- [F3]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $13.66 to $13.90.
Documents
Issuer
Odonate Therapeutics, Inc.
CIK 0001717452
Entity typeother
Related Parties
1- filerCIK 0001178579
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 4:01 PM ET
- Size
- 14.2 KB